Publication: Milestones of CRISPR/Cas9 system, promises and roadblocks
Loading...
Files
Program
KU-Authors
Organization Authors
Co-Authors
Date
Language
Type
Embargo Status
NO
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
In this issue of Cancer Treatment and Research Communications, Sarkar et al. describe CRISPR/Cas9-based gene-editing from its discovery to current views. Originally a bacterial adaptive immune system, CRISPR/Cas9 was adapted to mammalian cells as a tool to perform a wide range of actions given its capability of accurately targeting specific DNA loci. While the CRISPR/Cas9 system is readily used in laboratories as a research tool for a few years now, the first clinical trials have recently started utilizing this system in translational medicine. Although several obstacles have been resolved related to the usage of CRISPR/Cas9 on mammalian cells, the scientific community is facing new challenges with this technology.
Source
Publisher
Elsevier
Citation
item.page.haspartof
Source
Cancer Treatment and Research Communications
item.page.ispartofseries
item.page.edition
DOI
10.1016/j.ctarc.2021.100304
